$SEM

Thomas Daniel sold (to issuer) $1.3M of SEM

Thomas Daniel sold (to issuer) 80,035 shares of SELECT MEDICAL HOLDINGS CORP (SEM) at $16.50 ($1.32M total) on 2026-06-30.

Original reporting
SEC EDGAR · Thomas Daniel
Published Jul 1, 2026, 6:23 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 1, 2026, 6:27 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$SEM
Neutral
medium confidence
Mentioned
$SEM
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$SEMNeutralLow
01

Why it matters

The filing updates ownership after a director sale to the issuer; it may slightly influence sentiment but does not change company fundamentals based on the provided text.

02

Market read

Traders may note the insider reducing holdings, but the disclosure lacks any new guidance, deal, or regulatory catalyst.

03

What to watch

No 10b5-1 plan is indicated, but the filing does not explain motivation; also, the director’s role and diversification needs can drive sales independent of outlook.

Relevance 6/10Novelty 5/10Timing: after-hours/filing update on 2026-07-01 for a 2026-06-30 insider sale

Background

This is an SEC Form 4 insider transaction disclosure for Select Medical Holdings Corp (SEM).

Company-level read

Ticker impact

$SEMNeutralMedium confidence
Context

Select Medical Holdings director Thomas Daniel sold 80,035 shares to the issuer at $16.50 on 2026-06-30, leaving 0 shares.

Expected impact

Likely limited near-term impact; any effect would be sentiment-driven and small versus broader fundamentals.

Evidence & confidence

Form 4 discloses a completed transaction size/value (~$1.32M) and post-sale holdings (0 shares), but provides no new operating, guidance, or regulatory information.

Market effects

Minimal; insider sale in a single healthcare services name typically does not reset sector expectations.

None.

None.

Counterpoint

The sale is to the issuer (often buyback/plan mechanics) and may be administrative rather than a bearish view on the business.

Key entities

  • SELECT MEDICAL HOLDINGS CORP

    Subject of the Form 4 insider transaction; director Thomas Daniel sold shares to the issuer.

  • Thomas Daniel

    Director who sold 80,035 shares at $16.50 on 2026-06-30, leaving 0 shares.

Related articles

$QXOHighAI 9/10

Are KORE, SEM, BLD, QXO Obtaining Fair Deals for their Shareholders?

Halper Sadeh LLC said it is investigating potential securities-law or fiduciary-duty issues in deals involving KORE Group Holdings’ sale to Searchlight Capital Partners and Abry Partners for $9.25/share, Select Medical’s sale for $16.50/share, and TopBuild’s proposed acquisition by QXO. The firm also flagged QXO’s merger with TopBuild and said it may seek higher consideration or additional disclosures.

$QXOHighAI 9/10

Are KORE, SEM, BLD, QXO Obtaining Fair Deals for their Shareholders?

Halper Sadeh LLC said it is investigating potential securities-law violations and fiduciary-duty breaches involving KORE Group Holdings’ sale to Searchlight Capital Partners and Abry Partners for $9.25/share, Select Medical’s sale to a consortium led by its executives/directors for $16.50/share, and TopBuild’s proposed deal with QXO. TopBuild holders would choose $505 cash or 20.2 QXO shares per share.